Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 07 February 2019
      Stroke care: sharing the recipe for better outcomes
 
 
Winner of the Service Delivery Award 2018
 
The Angels Initiative, the Winner of the Service Delivery Award 2018, is changing lives and curbing costs by helping hospitals to be 'stroke ready'.

The Angels Initiative is a collaborative effort to increase the number of patients treated in stroke-ready hospitals, and to optimise the quality of treatment in all existing stroke centres. Initiated by Boehringer-Ingelheim as a non-promotional project, and backed by the World Stroke Organization, the European Stroke Organization (ESO), the Stroke Alliance for Europe (SAFE), along with institutional and academic partners, it is raising standards across Europe and around the globe.
Read more →
 
 
      News
 
  06 February 2019 Open Letter from EFPIA President Dr Stefan Oschmann on the SPC manufacturing waiver

For our sector, it is essential that Europe's world-class protection of intellectual property rights be guaranteed in...

Read more →
 
 
 
      Blogs
 
  04 February 2019 Three steps to better cancer outcomes

The impact of cancer is growing but stakeholders are coming together to chart a course to a sustainable new approach...

Read more →
 
 
 
  04 February 2019 #WorldCancerDay: We aim to create a world without cancer

To mark World Cancer Day, 4 February, Kees Roks from Novartis Oncology assesses the big trends shaping the future of...

Read more →
 
 
 
  01 February 2019 Data points

A blog by Deepak Khanna, Senior Vice President and Regional President, EMEAC Oncology for MSD

Read more →
 
 
 
      Events
 
 
14 FEB 2019
  7th ACCELERATE Paediatric Oncology Conference Steigenberger Wiltcher’s, Avenue Louise 71, Brussels, Belgium

An international platform of all diverse stakeholders caring about accelerating new oncology drug development for children...

Learn more →
 
 
 
06 MAR 2019
  EU Ecosystem For Monitoring Of Post-Licensure Vaccine Benefit And Risk: From ADVANCE... Brussels

An IMI's multi stakeholder conference

Learn more →
 
 
      What we are reading
Easier and more secure access to health data across borders 06 February 2019  (European Commission) Read more →
Vaccines and infectious diseases in the ageing population project begins 05 February 2019  (European Pharmaceutical Review) Read more →
Investing more in research to step up the fight against cancer 05 February 2019  (The Parliament Magazine) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe